Evaluating the impact of axillary dissection on recurrence-free survival by extent of nodal disease in invasive lobular carcinoma of the breast.
Mary Kathryn AbelKelly Fahrner-ScottJasmine WongMichael AlvaradoCheryl EwingLaura J EssermanCatherine ParkRita A MukhtarPublished in: Breast cancer research and treatment (2020)
These findings support the safety of omitting ALND in selected patients with ILC. Further studies of axillary management in ILC and imaging tools to predict nodal involvement and therapeutic response are warranted.